• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性瘙痒的治疗选择

Treatment Options for Troublesome Itch.

作者信息

Toyama Sumika, Tominaga Mitsutoshi, Takamori Kenji

机构信息

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan.

Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan.

出版信息

Pharmaceuticals (Basel). 2022 Aug 19;15(8):1022. doi: 10.3390/ph15081022.

DOI:10.3390/ph15081022
PMID:36015170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412524/
Abstract

Itch (or pruritus) is an unpleasant sensation, inducing the desire to scratch. It is also a major and distressing symptom of many skin and systemic diseases. The involvement of histamine, which is a major itch mediator, has been extensively examined. Recent studies suggest that histamine-independent pathways may play roles in chronic itch. Therefore, antihistamines are not always effective in the treatment of patients with chronic itch. The development of biologics and κ-opioid receptor (KOR) agonists has contributed to advances in the treatment of itch; however, since biologics are expensive for patients to purchase, some patients may limit or discontinue their use of these agents. Furthermore, KOR agonists need to be prescribed with caution due to risks of side effects in the central nervous system. Janus kinase (JAK) inhibitors are sometimes associated with side effects, such as infection. In this review, we summarize antidepressants, antineuralgics, cyclosporine A, antibiotics, crotamiton, phosphodiesterase 4 inhibitor, botulinum toxin type A, herbal medicines, phototherapy, and acupuncture therapy as itch treatment options other than antihistamines, biologics, opioids, and JAK inhibitors; we also explain their underlying mechanisms of action.

摘要

瘙痒(或称作瘙痒症)是一种令人不适的感觉,会引发搔抓的欲望。它也是许多皮肤和全身性疾病的主要且令人苦恼的症状。组胺作为主要的瘙痒介质,其作用已得到广泛研究。近期研究表明,非组胺途径可能在慢性瘙痒中发挥作用。因此,抗组胺药在治疗慢性瘙痒患者时并不总是有效。生物制剂和κ-阿片受体(KOR)激动剂的研发推动了瘙痒治疗的进展;然而,由于生物制剂对患者来说购买成本高昂,一些患者可能会减少或停止使用这些药物。此外,由于存在中枢神经系统副作用的风险,KOR激动剂需要谨慎处方。Janus激酶(JAK)抑制剂有时会伴有副作用,如感染。在本综述中,我们总结了除抗组胺药、生物制剂、阿片类药物和JAK抑制剂之外的瘙痒治疗选择,包括抗抑郁药、抗神经痛药、环孢素A、抗生素、克罗米通、磷酸二酯酶4抑制剂、A型肉毒毒素、草药、光疗和针灸疗法;我们还解释了它们潜在的作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/51b1b09ff411/pharmaceuticals-15-01022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/b207862e75fd/pharmaceuticals-15-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/5db65145fc26/pharmaceuticals-15-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/99a2513b8ca0/pharmaceuticals-15-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/51b1b09ff411/pharmaceuticals-15-01022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/b207862e75fd/pharmaceuticals-15-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/5db65145fc26/pharmaceuticals-15-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/99a2513b8ca0/pharmaceuticals-15-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3faf/9412524/51b1b09ff411/pharmaceuticals-15-01022-g004.jpg

相似文献

1
Treatment Options for Troublesome Itch.顽固性瘙痒的治疗选择
Pharmaceuticals (Basel). 2022 Aug 19;15(8):1022. doi: 10.3390/ph15081022.
2
Current topical and systemic therapies for itch.目前用于治疗瘙痒的局部和全身疗法。
Handb Exp Pharmacol. 2015;226:337-56. doi: 10.1007/978-3-662-44605-8_18.
3
Intractable Itch in Atopic Dermatitis: Causes and Treatments.特应性皮炎中的顽固性瘙痒:病因与治疗
Biomedicines. 2021 Feb 25;9(3):229. doi: 10.3390/biomedicines9030229.
4
Itch associated with skin disease: advances in pathophysiology and emerging therapies.与皮肤疾病相关的瘙痒:病理生理学进展与新兴疗法
Am J Clin Dermatol. 2003;4(9):617-22. doi: 10.2165/00128071-200304090-00004.
5
Breaking the Itch-Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis.打破瘙痒-搔抓循环:特应性皮炎慢性皮肤瘙痒管理的局部用药选择
Medicines (Basel). 2019 Jul 18;6(3):76. doi: 10.3390/medicines6030076.
6
Neurologic Itch Management.神经病理性瘙痒的管理
Curr Probl Dermatol. 2016;50:116-23. doi: 10.1159/000446053. Epub 2016 Aug 23.
7
Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.在瘙痒小鼠模型中研究β抑制蛋白2在κ阿片受体调节中的作用。
Neuropharmacology. 2015 Dec;99:600-9. doi: 10.1016/j.neuropharm.2015.08.027. Epub 2015 Aug 25.
8
Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.治疗特应性皮炎患者瘙痒的小分子药物。
Eur J Pharmacol. 2020 Aug 15;881:173242. doi: 10.1016/j.ejphar.2020.173242. Epub 2020 Jun 3.
9
Chronic pruritus: targets, mechanisms and future therapies.慢性瘙痒:靶点、机制及未来疗法
Drug News Perspect. 2008 Dec;21(10):541-51. doi: 10.1358/dnp.2008.21.10.1314057.
10
Atopic itch in dogs: pharmacology and modeling.犬特应性瘙痒:药理学与模型构建
Handb Exp Pharmacol. 2015;226:357-69. doi: 10.1007/978-3-662-44605-8_19.

引用本文的文献

1
Effects of Narrowband Ultraviolet B Therapy on the Skin Barrier in a Murine Model of Dry Skin.窄谱中波紫外线疗法对干性皮肤小鼠模型皮肤屏障的影响
Photodermatol Photoimmunol Photomed. 2025 May;41(3):e70016. doi: 10.1111/phpp.70016.
2
A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy.特应性皮炎光疗的综合综述:作用机制、治疗方式及临床疗效
Cureus. 2024 Mar 25;16(3):e56890. doi: 10.7759/cureus.56890. eCollection 2024 Mar.
3
Effects of Dupilumab on Itch-Related Events in Atopic Dermatitis: Implications for Assessing Treatment Efficacy in Clinical Practice.

本文引用的文献

1
Association Between Inflammatory Bowel Disease and Pruritus.炎症性肠病与瘙痒之间的关联。
Crohns Colitis 360. 2020 Feb 28;2(1):otaa012. doi: 10.1093/crocol/otaa012. eCollection 2020 Jan.
2
Peripheral itch sensitization in atopic dermatitis.特应性皮炎的外周瘙痒敏化。
Allergol Int. 2022 Jul;71(3):265-277. doi: 10.1016/j.alit.2022.04.003. Epub 2022 May 25.
3
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective.从英国视角评估一种 JAK 抑制剂与一种单克隆抗体治疗中重度特应性皮炎的经济学评价。
度普利尤单抗对特应性皮炎瘙痒相关事件的影响:对临床实践中评估治疗效果的启示。
Cells. 2023 Jan 5;12(2):239. doi: 10.3390/cells12020239.
4
Role of GRPR in Acupuncture Intervention in the "Itch-scratch Vicious Cycle" Spinal Circuit of Chronic Pruritus.胃泌素释放肽受体在慢性瘙痒“瘙痒-搔抓恶性循环”脊髓回路针刺干预中的作用
Chin Med. 2023 Jan 3;18(1):2. doi: 10.1186/s13020-022-00706-4.
5
How Does Botulinum Toxin Inhibit Itch?肉毒杆菌毒素如何抑制瘙痒?
Toxins (Basel). 2022 Oct 12;14(10):701. doi: 10.3390/toxins14100701.
J Med Econ. 2022 Jan-Dec;25(1):491-502. doi: 10.1080/13696998.2022.2059220.
4
The Anti-Inflammatory and Anti-Pruritus Mechanisms of Huanglian Jiedu Decoction in the Treatment of Atopic Dermatitis.黄连解毒汤治疗特应性皮炎的抗炎及止痒机制
Front Pharmacol. 2021 Dec 2;12:735295. doi: 10.3389/fphar.2021.735295. eCollection 2021.
5
Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial.地法米司特软膏治疗成人特应性皮炎:一项3期随机、双盲、赋形剂对照试验。
J Am Acad Dermatol. 2022 Mar;86(3):607-614. doi: 10.1016/j.jaad.2021.10.027. Epub 2021 Oct 25.
6
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.在患有轻度至中度特应性皮炎和其他特应性合并症的患者中,crisaborole 的疗效和安全性。
Allergy Asthma Proc. 2021 Sep 1;42(5):425-431. doi: 10.2500/aap.2021.42.210064.
7
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.乌帕替尼对比度普利尤单抗治疗成人中重度特应性皮炎的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2021 Sep 1;157(9):1047-1055. doi: 10.1001/jamadermatol.2021.3023.
8
Efficacy and safety of topical OPA-15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double-blind, placebo-controlled study.新型磷酸二酯酶4抑制剂局部用OPA-15406治疗日本特应性皮炎患者8周的疗效和安全性:一项2期随机双盲安慰剂对照研究
J Dermatol. 2019 Aug;46(8):672-679. doi: 10.1111/1346-8138.14979. Epub 2019 Jun 19.
9
Effects of Josamycin on Scratching Behavior in NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions.交沙霉素对特应性皮炎样皮损 NC/Nga 小鼠搔抓行为的影响。
Biol Pharm Bull. 2021;44(6):798-803. doi: 10.1248/bpb.b20-00976.
10
Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease.应用肉毒毒素治疗小儿 Fox-Fordyce 病瘙痒
Pediatr Dermatol. 2021 Jul;38(4):950-951. doi: 10.1111/pde.14552. Epub 2021 Jun 1.